Skip to main content

Table 1 Demographics of study population

From: Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African Americans

Trait Caucasian or European-American (CA) African-American (AA)
N 99 37
Gender (M/F) 42/57 21/16
Age (Yrs) 39.7 ± 10.9 42.1 ± 9.1
WHR 0.89 ± 0.19 0.89 ± 0.07
BMI (kg/m2) 28.2 ± 4.9 29.5 ± 6.3
% Fat mass 32.6 ± 9.0 29.6 ± 10.9
Triacylglycerol (mmol/l) 1.45 ± 1.36 1.14 ± 0.71
Total Cholesterol (mmol/l) 4.75 ± 0.92 4.47 ± 1.01
LDL Cholesterol (mmol/l) 2.75 ± 0.76 2.56 ± 0.89
HDL cholesterol (mmol/l) 1.39 ± 0.47 1.38 ± 0.33
Fasting Glucose (mmol/l) 4.74 ± 0.46 4.72 ± 0.53
2 h Glucose (mmol/L) 5.80 ± 1.63 5.51 ± 1.91
Fasting Insulin (pmol/l) 43.6 ± 39.8 46.6 ± 61.2
HOMA-IR 1.36 ± 1.34 1.50 ± 2.35
Matsuda Index 7.60 ± 5.48 9.18 ± 6.12
SI (×10−4.min−1 [μU/ml]−1)* 3.8 ± 2.3 3.4 ± 1.9
AIRG (pmol/L)* 2860 ± 2177 4586 ± 3148
DI* 1515 ± 1144 2061 ± 1257
  1. Continuous variables are shown as mean ± SD. Metabolic measurements from OGTT; *Metabolic traits from MINMOD analysis of FSIGT evaluation of non-diabetic individuals. BMI, Body mass index; WHR, waist to hip ratio; LDL, Low density lipoprotein; HDL, High Density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; SI, insulin sensitivity index; AIRG, Acute insulin response to glucose; DI, Disposition index. Units are taken from MINMOD program.